Placebo effect in rheumatology: Novelties;L'effet placebo en rhumatologie: Des nouveautés

Revue du Rhumatisme (Edition Francaise)

Volumn 78, Issue 1, 2011, Pages 32-36

  Berthelot, Jean Marie ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78751517887     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rhum.2010.05.018     Document Type: Short Survey

References (59)

1. P. Enck, P. Benedetti, and M. Schedlowski New insights into the placebo and nocebo responses Neuron 59 2008 195 206
2. A. Pollo, and F. Benedetti Placebo response: relevance to the rheumatic diseases Rheum Dis Clin North Am 34 2008 331 349
3. M. Breidert, and K. Hofbauer Placebo: misunderstandings and prejudices Dtsch Artzebl Int 106 2009 751 755
4. I. Gilron, J.M. Bailey, and D. Tu Morphine, gabapentin, or their combination for neuropathic pain N Engl J Med 352 13 2005 1324 1334
5. J.M. Berthelot, A. Blanchais, and T. Marhadour Fluctuations in disease activity scores for inflammatory joint disease in clinical practice: do we need a solution? Joint Bone Spine 76 2009 126 128
6. J.M. Berthelot, L. Tortellier, and D. Lavy-Bregeon High intra-individual week-to-week variability in BASDAI and BASFI values: are several evaluations needed before starting or stopping TNFalpha antagonist therapy for spondyloarthropathies? Joint Bone Spine 75 2008 167 171
7. P.T. Nieuwkerk, and M.A.G. Sprangers Each measure of patient-reported change provides useful information and is susceptible to bias: the need to combine methods to assess their relative validity Arthritis Care Res 61 2009 1623 1625
8. A. Hrobjartsoon, and P.C. Gotzsche Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment N Engl J Med 344 2001 1594 1602
9. B.E. Wampold, T. Minami, and S.C. Tierney The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials J Clin Pscyhol 61 2005 835 854
10. A.L. Geers, K. Kosbab, and S.G. Helfer Further evidence for individual differences in placebo responding: an interactionist perspective J Psychosom Res 62 2007 563 570
11. D.L. Morton, A. Watson, and W. El-Deredy Reproducibility of placebo analgesia: effect of dispositional optimism Pain 146 2009 194 198
12. L. Vase, J.L. Riley, and D.D. Price A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia Pain 99 2002 443 452
13. A. Hrobjartsson, and P.C. Gotzsche Unsubstantiated claims of large effects of placebo on pain: serious errors in meta-analysis of placebo analgesia mechanism studies J Clin Epidemiol 59 2006 336 338
14. T.D. Wager, J.K. Rilling, and E.E. Smith Placebo-induced changes in fMRI in the anticipation and experience of pain Science 303 2004 1162 1166
15. D.D. Price, J. Craggs, and G.N. Verne Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients Pain 127 2007 63 72
16. J. Kong, R.I. Gollub, and I.S. Rosman Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging J Neurosci 26 2006 381 388
17. D.J. Scott, C.S. Stohler, and C.M. Egnatuk Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses Arch Gen Psychiatry 65 2008 220 231
18. F. Benedetti, M. Lanotte, and L. Lopiano When words are painful: unravelling the mechanisms of the nocebo effect Neuroscience 147 2007 260 271
19. L. Colloca, and F. Benedetti Nocebo hyperalgesia: how anxiety is turned into pain Curr Opin Anaesthesiol 20 2007 435 439
20. D.G. Finnis, T.J. Kaptchuk, and F. Miller Biological, clinical, and ethical advances of placebo effects Lancet 375 2010 686 695
21. Y.H. Qiu, X.Y. Wu, and H. Xu Neuroimaging study of placebo analgesia in humans Neurosci Bull 25 2009 277 282
22. F. Eippert, J. Finsterbuch, and U. Bingel Direct evidence for spinal cord involvement in placebo analgesia Science 326 2009 404
23. D. Matre, K.L. Casey, and S. Knardahl Placebo-induced changes in spinal cord pain processing J Neurosci 26 2006 559 563
24. J. Kong, T.J. Kaptchuk, and G. Polich Placebo analgesia: findings from brain imaging studies and emerging hypotheses Rev Neurosci 18 2007 173 190
25. W. Zhang, J. Robertson, and A.C. Jones The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials Ann Rheum Dis 67 2008 1716 1723
26. B.G. Charlton Covert drug dependence should be the null hypothesis for explaining drug-withdrawal-induced clinical deterioration: The necessity for placebo versus drug withdrawal trials on normal control subjects Med Hypotheses 74 2010 761 763
27. R. Staud, and D.D. Price Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors Pain 136 2008 232 234
28. P. Krummenacher, V. Candia, and G. Folkers Prefrontal cortex modulates placebo analgesia Pain 148 2010 368 374
29. J.K. Zubieta, and C.S. Stohler Neurobiological mechanisms of placebo responses Ann N Y Acad Sci 1156 2009 198 210
30. R. De la Fuente-Fernandez The placebo-reward hypothesis: dopamine and the placebo effect Parkinsonism Relat Disord 15 Suppl. 3 2009 S72 S74
31. F.G. Miller, and D.L. Rosenstein The nature and power of the placebo-effect J Clin Epidemiol 59 2006 331 335
32. E.H. Turner, A.M. Matthews, and E. Linardatos Selective publication of antidepressant trials and its influence on apparent efficacy N Engl J Med 358 2008 252 260
33. L. Colloca, and F. Benedetti Placebo analgesia induced by social observational learning Pain 144 2009 28 34
34. L. Colloca, M. Sgaudo, and F. Benedetti The role of learning in nocebo and placebo effects Pain 136 2008 211 218
35. L. Colloca, L. Lopiano, and M. Lanotte Overt versus covert treatment for pain, anxiety, and Parkinson's disease Lancet Neurol 3 2004 679 684
36. E. Nüesch, S. Reichenbach, and S. Trelle The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study Arthritis Care Res 61 2009 1633 1641
37. I. Boutron, D. Moher, and D.G. Altman Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments Ann Intern Med 148 2008 W60 W66
38. T.J. Kaptchuk, J. Shaw, and C.E. Kerr "Maybe I made up the whole thing": placebos and patients' experiences in a randomized controlled trial Cult Med Psychiatry 33 2009 382 411
39. J.M. Berthelot, Y. Maugars, and M. Abgrall Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses Joint Bone Spine 68 2001 65 70
40. M.D. Van Die, K.M. Bone, and H.G. Burger Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial BMC Med Res Methodol 9 2009 41
41. H.H. Moffet Sham acupuncture may be as efficacious as true acupuncture: a systematic review of clinical trials J Altern Complement Med 15 2009 213 216
42. N. Takakura, and H. Yajima Analgesic effect of acupuncture needle penetration: a double-blind crossover study Open Med 19 2009 e54 61
43. J.P. Valat, B. Giraudeau, and S. Rozenberg Epidural corticosteroid injections for sciatica: a randomised, double blind, controlled clinical trial Ann Rheum Dis 62 2003 639 643
44. J.P. Valat, and S. Rozenberg Local corticosteroid injections for low back pain and sciatica Joint Bone Spine 75 2008 403 407
45. L. Klenerman, R. Greenwood, and H.T. Davenport Lumbar epidural injections in the treatment of sciatica Br J Rheumatol 23 1984 35 38
46. J.C. Licciardone, and D.P. Russo Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment J Am Osteopath Assoc 106 2006 457 463
47. C. Hawk, C.R. Long, and R. Reiter Issues in planning a placebo-controlled trial of manual methods: results of a pilot study J Altern Complement Med 8 2002 21 32
48. R. Forestier, H. Desfour, and J.M. Tessier Spa therapy in the treatment of knee osteoarthritis: a large randomised multicentre trial Ann Rheum Dis 69 2010 660 665
49. R. Forestier, J. André-Vert, and P. Guillez Non-drug treatment (excluding surgery) in rheumatoid arthritis: clinical practice guidelines Joint Bone Spine 76 2009 691 698
50. H. Dogru, S. Basaran, and T. Sarpel Effectiveness of therapeutic ultrasound in adhesive capsulitis Joint Bone Spine 75 2008 455 550
51. P. Fardellone, B. Cortet, and E. Legrand Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis Joint Bone Spine 77 2010 53 57
52. A.L. Martin, and J. Katz Inclusion of authorized deception in the informed consent process does not affect the magnitude of the placebo effect for experimentally induced pain Pain 149 2010 208 215
53. E.P. Cherniack Would the elderly be better off if they were given more placebos? Geriatr Gerontol Int 10 2010 131 137
54. F.G. Miller, and L. Colloca The legitimacy of placebo treatments in clinical practice: evidence and ethics Am J Bioeth 9 2009 39 47
55. W. Zhang, G. Nuki, and R.W. Moskowitz OARSI recommendations for the management of hip and knee osteoarthritis Part III: changes in evidence following systematic cumulative update of research published through January 2009 Osteoarthritis Cartilage 18 2010 476 499
56. D.F. Kallmes, B.A. Comstock, and P.J. Heagerty A randomized trial of vertebroplasty for osteoporotic spinal fractures N Engl J Med 361 2009 569 579
57. R. Buchbinder, R.H. Osborne, and P.R. Ebeling A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures N Engl J Med. 361 2009 557 568
58. J.T. Liu, W.J. Liao, and W.C. Tan Balloon kyphoplasty versus vertebroplasty for treatment of osteoporotic vertebral compression fracture: a prospective, comparative, and randomized clinical study Osteoporosis Int 21 2010 359 364
59. D. Wendling, M. Runge, and E. Toussirot Vertebral osteitis adjacent to kyphoplasty Joint Bone Spine 77 2010 67 69